Characterisation of Fundamental Decision Making in People Suffering From a Characterised Depressive Episode
NCT05654948, Completed, University Hospital, Tours
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Characterisation of Fundamental Decision Making in People Suffering From a Characterised Depressive Episode | ClinicalTrials.gov |
| NCT number | NCT05654948 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Enrollment | 80 participants, actual | ClinicalTrials.gov |
| Lead sponsor | University Hospital, Tours | ClinicalTrials.gov |
| Conditions | Depressive Episode | ClinicalTrials.gov |
| Interventions | computerised cognitive performance test : MindPulse | ClinicalTrials.gov |
| First posted | 2022-12-16 | ClinicalTrials.gov |
| Last updated | 2024-12-09 | ClinicalTrials.gov |
Registered outcomes 12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | MADRS score | baseline | The severity of the depression will be assessed using the MADRS score. Montgomery-Asberg Depression Scale (MADRS) The scale has 10 items rated from 0 to 6. 0 to 6 points: the patient is considered healthy. 7 to 19 points: the patient is considered to be in mild depression. 20 to 34 points: the patient is considered to be in moderate depression. \> 34 points: the patient is considered to be in severe depression. | ClinicalTrials.gov |
| Primary | Simple reaction time (SRT) obtained at the MindPulse test | Baseline | The "simple reaction time" (SRT) is the reaction time to the first test (the subject releases the mouse click as quickly as possible when an image appears) , it contains the time needed to perceive and analyse the image, to formulate the response and to execute the motor response. | ClinicalTrials.gov |
| Primary | Go/NoGo score obtained at the MindPulse test | Baseline | reaction time with a categorisation where the subject must react or not react (Go/NoGo) according to the categorical target, in this case a light or dark colour (white coloured image or grey coloured image). | ClinicalTrials.gov |
| Primary | Executive speed (ES) obtained at the MindPulse test | Baseline | The ES Score corresponds to the Executive Speed, i.e. the average time of categorisation of the subject. | ClinicalTrials.gov |
| Primary | Reaction to difficulty obtained at the MindPulse test | Baseline | It corresponds to the adaptation of the subject to the level of difficulty. The shift of the circle above the blue rectangle indicates a higher than expected slowing down in reaction to the difficulty of the instruction, while a shift below the blue rectangle indicates that the participant is not slowing down enough in response to the difficulty and is at risk of making mistakes. | ClinicalTrials.gov |
| Secondary | Level of anxiety | Baseline | measured by a self-questionnaire : State Trait Anxiety Inventory (STAI) 40 items rated from 1 to 4 | ClinicalTrials.gov |
| Secondary | clinical characterisation | Baseline | Measured by a scale : Transdiagnostic Skills Scale (T2S) 42 items rated from 1 to 7 | ClinicalTrials.gov |
| Secondary | clinical characterisation | Baseline | Measured by a questionnaire : Transdiagnostic Evaluation Scale (ETE) 66 items rated from 1 to 7 | ClinicalTrials.gov |
| Secondary | insomnia severity | Baseline | Measured by an insomnia severity index (ISI) 5 items rated from 0 to 4 | ClinicalTrials.gov |
| Secondary | Stroop test | Baseline | standardised cognitive assessment is measured by neuropsycological tests as stroop test | ClinicalTrials.gov |
| Secondary | D2R | Baseline | standardised cognitive assessment is measured by neuropsycological tests as D2R test that measures the concentration | ClinicalTrials.gov |
| Secondary | Finger tapping test | Baseline | standardised cognitive assessment is measured by neuropsycological tests as Finger tapping test rated from 0 to 4 | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Go/No-Go Task | Primary outcome | ConductCognition |
| Simple Reaction Time | Primary outcome | ConductCognition |
| Finger Tapping Task | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)